Skip to main content
. 2014 Jun 4;2014:893243. doi: 10.1155/2014/893243

Figure 2.

Figure 2

Kaplan-Meier analysis of (a) progression free survival (PFS) and (b) overall survival (OS) in groups of patients positive and negative for CD33 and CD13. CD33 expression demonstrates a potential prognostic impact and was associated with lower OS (P = 0.001). Patients with CD13 associated with significantly shorter PFS times (P = 0.008), not only lower OS (P = 0.025).